The Official News & Technical Journal Of The International Society For Pharmacoeconomics And Outcomes Research

Short Courses Again Popular at ISPOR 6th Annual European Congress
Lindsay Augustyniak, ISPOR Manager, Meetings and Educational Services

 

Once again, the ISPOR Short Courses were very successful at the Annual European Congress. Over 300 people took part in attending the Short Courses, which included 1 all-day course on Saturday, and 6 sessions on Sunday morning. Enthusiastic meeting attendance again caused classes to swell close to maximum capacity.
 

Joephine Mauskopf PhD
and Daniel Mullins PhD, Cost Estimation and Assessing Financia Impact of New Health Care Technologies Short Course


For the third straight year, eight-hour Saturday offering of a pharmacoeconomics course Pharmacoeconomics for the Health Care Decision-Maker was a success. The course was taught by Lieven Annemans PhD, Ms, Mman, University of Ghent, Meise, Belgium, and Pedro Plans-Rubio MD, MBA, Evaluation Unit, Department of Sanitat, Sant Pol, Spain.

Uwe Siebert MPh, MSc,
Advanced Pharmacoeconomic Modeling Short Course
 
     
Maite Artes MSc, Meta-Analysis and Systematic Literature Review- Introduction Short Course Christian Gericke MD, MSc,
DTMH Evidence-Based Health Care Reimbursement Systems in Europe – NICE and Beyond


The Sunday courses were: Cost Estimation and Assessing Financial (Budget) Impact of New HealthCare Technologies, taught by Josephine Mauskopf PhD, Division Director, Global Health Economics, RTI Health Solutions, RTI International, RTP, NC, USA; and C. Daniel Mullins PhD, Professor, University of Maryland, School of Pharmacy, Baltimore, MD, USA; Evidence-Based Health Care Reimbursement Systems in Europe - NICE and Beyond, taught by Christian Gericke, MD, MSc, DTMH Dept of Health Care Management, Technische Universität Berlin, Berlin, Germany; Value/Valuation in Measuring Outcomes (Preference-Based Techniques), taught by Jan Busschbach PhD, Department of Medical Psychology, Erasmus MC, Rotterdam, Psychotherapeutic Centre ‘De Viersprong’, Rotterdam, The Netherlands; Advanced Pharmacoeconomic Modeling, taught by Uwe Siebert MPh, MSc, Harvard School of Public Health, Harvard Center for Risk Analysis, Boston, MA, USA, and Gaby Sroczynski, MPH, Decision Scientist, Harvard Center for Risk Analysis, Harvard School of Public Health, Boston, USA; Meta-Analysis and Systematic Literature Review – Introduction, taught by Maite Artes MSc, General Manager, ADELPHI TARGIS, Barcelona, Spain and Mateu Serra-Prat MD, MPH, Head of the Research Unit, Consorci Sanitari del Maresme CSdM, Barcelona, Spain; and The Analysis and Interpretation of Quality of Life and Patient Reported Outcomes, taught by Linda Abetz MA, Research Director, Mapi Values, Bollington, UK and Bruce Crawford MA, MPH, Project Director, Mapi Values, Boston, MA, USA.


  Issues Index | 2003 Issues Index